ANRS | Maladies infectieuses émergentes (ANRS | MIE) is the French National Agency for Research on HIV/AIDS, Viral Hepatitis, Sexually Transmitted Infections, Tuberculosis, and Emerging Infectious Diseases. As an autonomous agency of Inserm (French National Institute of Health and Medical Research), its mission is to drive, coordinate, evaluate, and fund public research in these critical areas. Formed on January 1, 2021, through the merger of the historical ANRS and the REACTing consortium, ANRS | MIE plays a pivotal role in responding to health crises, fostering scientific innovation, and translating research findings into public health benefits both in France and internationally. The agency supports a wide spectrum of research, from fundamental science to clinical trials, public health studies, and social science investigations, aiming to improve prevention, diagnosis, treatment, and patient care for infectious diseases.
The Paris headquarters serves as the central administrative and coordinating body for the agency's national and international research programs, funding allocation, strategic planning, and partnership management.
Located within a major urban research and academic environment, facilitating close collaboration with partner institutions. The specific building is part of modern office infrastructure within Paris.
The work culture at ANRS | MIE headquarters is characterized by a strong commitment to public health, scientific excellence, collaboration, and responsiveness to emerging health threats. It involves dynamic interaction between researchers, policymakers, and healthcare professionals.
The headquarters is significant as it is the nerve center for France's publicly funded research efforts against major infectious diseases, directing national strategy and international cooperation in this field.
ANRS | MIE has a significant global presence, primarily through its international research collaborations, funding of projects in low- and middle-income countries, and participation in global health initiatives. The agency supports numerous research sites and programs in Sub-Saharan Africa, Southeast Asia, and South America, focusing on diseases with high burden in these regions like HIV, viral hepatitis, tuberculosis, and emerging infections. This global engagement aims to build local research capacity, foster equitable partnerships, and ensure that research findings benefit populations worldwide. ANRS | MIE actively collaborates with international organizations, research consortia, and foreign governmental agencies to advance global health security and research equity.
101 Rue de Tolbiac
Paris
Île-de-France
France
Address: Collaborates with local institutions like Centre Pasteur du Cameroun (specific project addresses vary)
To strengthen research capacity, address specific regional health priorities, and foster North-South scientific collaborations in the fight against infectious diseases in Central Africa.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, ANRS' leadership includes:
ANRS has been backed by several prominent investors over the years, including:
No major publicly announced executive hires or exits at the top leadership level (Director, Deputy Director, Secretary General) of ANRS | Maladies infectieuses émergentes have been identified in the last 12 months. The current core leadership team has been largely consistent since the agency's restructuring in 2021.
Discover the tools ANRS uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
ANRS | Maladies infectieuses émergentes likely utilizes email formats common for French public research institutions. The most probable format is based on the employee's first and last name. Generic contact emails like presse@anrs.fr are also used for specific departments.
[first].[last]@anrs.fr
Format
sophie.martin@anrs.fr
Example
75%
Success rate
ANRS MIE Website • 2024-05-28
ANRS | MIE and Sidaction are launching a joint call for projects to combat the stigmatization of people living with HIV. This initiative aims to support research and actions that reduce discrimination and improve the quality of life for those affected....more
ANRS MIE Website • 2024-04-25
On World Malaria Day, ANRS | MIE highlights its commitment to malaria research, supporting various projects aimed at prevention, treatment, and control of the disease, particularly in affected regions....more
ANRS MIE Website • 2024-03-28
ANRS | MIE is launching HEPATHER-cohort, a new cohort study focused on Hepatitis Delta, to advance research into this severe form of viral hepatitis, improve understanding, and develop better therapeutic strategies....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including ANRS, are just a search away.